Last reviewed · How we verify
Urinary test
At a glance
| Generic name | Urinary test |
|---|---|
| Sponsor | French Cardiology Society |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Hypertension
- Urinary tract infection
- Dry mouth
- Nasopharyngitis
Key clinical trials
- Adenosine 2A Receptor Antagonism and AIH in ALS (PHASE1, PHASE2)
- Physical Impairments in Children With Cystic Fibrosis
- Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer (PHASE2, PHASE3)
- Urine and Ultrasound Screening for Kidney Disease in Children (NA)
- Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care (NA)
- Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal
- Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
- Urinary Antigen Test for Stretococcus Pneumoniae Serotype Prevalence in Community Acquired Pneumonia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Urinary test CI brief — competitive landscape report
- Urinary test updates RSS · CI watch RSS
- French Cardiology Society portfolio CI